Factors affecting survival to intestinal transplantation in the very young pediatric patient

Sameera I Mian1, Sanjeev Dutta, Brian Le

  • 1Department of Pediatric Gastroenterology, Stanford University School of Medicine, Palo Alto, CA, USA.

Transplantation
|May 14, 2008
PubMed

Insights

For children under 18 months awaiting intestinal transplants, smaller body size and advanced liver disease are key risk factors. Intestinal atresia and retaining the ileocecal valve also increase mortality risk.

Area of Science:

  • Pediatric Surgery
  • Transplantation Medicine
  • Gastroenterology

Background:

  • High mortality rates in pediatric patients awaiting intestinal transplantation due to organ scarcity and complications.
  • Focus on identifying specific risk factors for survival in infants under 18 months.

Purpose of the Study:

  • To compare risk factors between pediatric patients who received intestinal grafts and those who died on the waiting list.
  • To identify factors influencing survival to intestinal transplantation in infants.

Main Methods:

  • Retrospective study of 22 pediatric patients (≤18 months) undergoing intestinal transplantation over 4 years.
  • Comparison of demographic, clinical, and diagnostic factors between transplanted and deceased groups.

Main Results:

  • No significant differences in bowel length, colon presence, or line infections.
  • Transplanted group had higher average body weight; deceased group showed more hepatic dysfunction.
  • Intestinal atresia was more common in the deceased group; ileocecal valve was retained in 80% of deceased vs. 0% of transplanted.

Conclusions:

  • Small body size and advanced liver disease are critical risk factors for intestinal transplantation survival in children under 18 months.
  • Intestinal atresia and ileocecal valve presence may increase mortality risk in this pediatric population.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...